National Vision SEC Filings

FAHS L Reade, Executive Chairman and Director of National Vision Holdings, Inc. (EYE), reported two open-market sales of company common stock on 09/15/2025 and 09/16/2025 executed under a Rule 10b5-1 trading plan established May 28, 2025. The filing shows a sale of 2,002 shares on 09/15/2025 at a weighted average price of $23.81 and a sale of 10,598 shares on 09/16/2025 at a weighted average price of $23.93. After those transactions the reporting person directly beneficially owned 532,195 shares. The filing also discloses 363,430 shares indirectly held by a trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.

National Vision Holdings insider transactions disclosed on a Form 144 show proposed and recent sales of common stock by an insider. The filing lists a proposed sale of 10,598 shares through Fidelity Brokerage, with an aggregate market value of $253,629.05, and an approximate sale date of 09/16/2025 on NASDAQ. The securities were acquired via a stock option exercise on 08/16/2021 and paid for in cash. The filing also reports two sales by Leonard R. Fahs on 08/28/2025 (137,400 shares, $3,343,335.27) and 09/15/2025 (2,002 shares, $47,670.10).

National Vision Holdings (EYE): Chief Technology Officer David G. Cutler received 25,997 restricted stock units (RSUs) on 09/08/2025. Each RSU converts one-for-one into common stock, and the full grant equals 25,997 shares outstanding following the award. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, so one-third vests each year. The reported position is held directly and the RSUs were granted at a $0 per-share exercise price (standard for restricted stock units). This is a routine equity compensation award to an executive designed to align compensation with shareholder interests.

National Vision Holdings insider award: Ana Moeddel, SVP and Chief Merchandising & MC Officer, was granted 34,185 restricted stock units (RSUs) on 09/02/2025. Each RSU converts one-for-one into common stock of the company. The award is reported as direct ownership of 34,185 shares following the grant and carries a reported price of $0. One-third of the RSUs will vest on each anniversary of the grant date, beginning September 2, 2025. The Form 4 was signed by an attorney-in-fact on 09/03/2025.

Insider sales by Executive Chairman Fahs L. Reade were disclosed on Form 4 for National Vision Holdings, Inc. (EYE). The filing reports two separate open-market sales executed on 08/28/2025 under a Rule 10b5-1 trading plan established May 28, 2025, totaling 137,400 shares sold at weighted-average prices of $23.85 and $24.76. After the transactions the reporting person is shown with directly beneficial ownership of 617,525 shares on one line and 544,795 shares on another line, and indirect beneficial ownership of 363,430 shares held by a trust. The Form 4 was signed by an attorney-in-fact.

National Vision Holdings, Inc. (EYE) filed a Form 144 indicating a proposed sale of 137,400 common shares to be executed through Fidelity Brokerage Services LLC. The filing shows an aggregate market value of $3,343,335.27 and reports 79,196,383 shares outstanding for the issuer, with an approximate sale date of 08/28/2025. The shares were acquired on 08/16/2021 through a stock option exercise and payment was made in cash.

The filing form lacks identifying filer contact details (CIK, submission contact name, phone, and email are not provided in the content). It also states "Nothing to Report" for securities sold during the past three months.

Wilkes Alexander, who is listed as both Chief Executive Officer and a director of National Vision Holdings, Inc. (EYE), reported transactions related to restricted stock units (RSUs) on 08/19/2025. A tranche of 61,785 RSUs vested and converted one-for-one into common stock. To satisfy tax withholding on vesting, 25,189 shares were withheld at a price of $23.61, leaving an incremental 36,596 shares delivered from the vesting. After the reported transactions, the filing shows 247,115 shares beneficially owned by the reporting person. The RSU grant that produced this vesting was originally awarded on 08/19/2024 for 185,357 RSUs, scheduled to vest in three equal annual installments. The Form 4 was signed by an attorney-in-fact.